Discover 2,355 paid clinical trials in Joliet, Illinois. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 2,355
Study to Evaluate the Safety, Tolerability & Efficacy of TNG462 in Combination in PDAC & NSCLC Patients
Location: Chicago IL, St Louis MO, Nashville TN, Omaha NE,
Sponsor: XVIVO Perfusion
Sex: All
Age: 18+
Code: NCT06895070
Recruiting
A Study of AAV2-GDNF in Adults With Moderate Parkinson's Disease (REGENERATE-PD)
for
Parkinson Disease
Location: Chicago IL, Madison WI, East Lansing MI,
Sponsor: AskBio Inc
Sex: All
Age: 45 - 70+
Code: NCT06285643
Phase2, Recruiting
A Study of Nipocalimab or Intravenous Immunoglobulin (IVIG) in Pregnancies At Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT)
for
Thrombocytopenia, Neonatal Alloimmune
Location: Park Ridge IL, Iowa City IA, Cincinnati OH,
Sponsor: Janssen Research & Development, LLC
Sex: Female
Age: 18 - 45
Code: NCT06533098
Phase3, Recruiting
Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer
for
Buccal Mucosa Squamous Cell Carcinoma,
Location: Chicago IL, Oak Creek WI, New Berlin WI, Milwaukee WI,
Sponsor: NRG Oncology
Sex: All
Age: 18+
Code: NCT04333537
Phase2, Phase3, Recruiting
A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer
for
Small Cell Lung Cancer
Location: Chicago IL, St Louis MO, Cincinnati OH, Lexington KY,
Sponsor: Daiichi Sankyo
Sex: All
Age: 18+
Code: NCT06203210
Phase3, Recruiting
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
for
Carcinoma, Non-Small-Cell Lung
Location: Chicago IL, Zion IL, Peoria IL, Decatur IL,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT06667076
Phase2, Recruiting
Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial
for
Non-Muscle Invasive Bladder Urothelial Carcinoma,
Location: Chicago IL, Normal IL, Urbana IL, Danville IL,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06770582
Phase2, Recruiting
Gut Microbiota-Mediated Inflammatory Interactions Between AUD and HIV Infection
for
Alcohol Use Disorder, Human Immunodeficiency Virus
Location: Chicago IL
Sponsor: Rush University Medical Center
Sex: All
Age: 45 - 70+
Code: NCT06139224
Recruiting
Safety and Efficacy of p53 Gene Therapy Combined With Immune Checkpoint Inhibitors in Solid Tumors.
for
Solid Tumor, Lymphoma
Location: Chicago IL, Morristown NJ
Sponsor: MultiVir, Inc.
Sex: All
Age: 18+
Code: NCT03544723
Phase2, Recruiting
A Study of Daratumumab and Dose-Adjusted EPOCH in Plasmablastic Lymphoma
for
Plasmablastic Lymphoma,
Location: Chicago IL, Columbus OH, Chapel Hill NC, Baltimore MD,
Sponsor: AIDS Malignancy Consortium
Sex: All
Age: 18+
Code: NCT04139304
Early_phase1, Recruiting
EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)
for
Breast Cancer
Location: Chicago IL, Wauwatosa WI, Newburgh IN, Edgewood KY,
Sponsor: Exact Sciences Corporation
Sex: All
Age: 18+
Code: NCT06401421
Recruiting
A Study of (LY3527727) Pirtobrutinib in Participants With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma